Respipure Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2022.
2022 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Respipure Pharma Private Limited

Respipure Pharma Private Limited, a active private limited company, was established on 27 January 2022 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290MH2022PTC375528. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹5.50 Cr and a paid-up capital of ₹1.00 Cr.

Its leadership includes Shekhar Shrawankumar Bhuwania (Director), Manish Shah Mangilal (Director), Nishant Vaish (Director). Past directors included Shekhar Shrawankumar Bhuwania. It holds ₹77.43 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop-75,Floor-7Th,Plot-215, Free Press, House Free Press Journal Marg, Nariman Point, Mumbai, Maharashtra, 400021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290MH2022PTC375528

  • Registration Number

    375528

  • Incorporation Date

    27 January 2022

  • Authorized Capital

    ₹5.50 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.50 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 4 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 77.43 Cr
Company report

Respipure Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Respipure Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Respipure Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Shekhar Shrawankumar Bhuwania Director 15 Jun 2022 Current
Manish Shah Mangilal Director 27 Jan 2022 Current
Nishant Vaish Director 27 Jan 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Respipure Pharma.

Respipure Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Respipure Pharma revenue growth over time
Respipure Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Respipure Pharma?

In 2023, Respipure Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹774,300,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 77.43 Cr
Latest Charge Details
Date Lender Amount Status
30 Apr 2025 Hdfc Bank Limited ₹1.50 M Open
18 Oct 2023 Hdfc Bank Limited ₹38.64 Cr Open
19 Dec 2022 Hdfc Bank Limited ₹38.64 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Respipure Pharma?

Respipure Pharma has a workforce of 0 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Respipure Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Respipure Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Respipure Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Respipure Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 38.64 Cr registered on 18 Oct 2023 with Charge ID 100806250 was modified on 26 Aug 2025. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 101109538 was registered on 30 Apr 2025. was recorded as a recent event.

  • Balance Sheet

    Respipure Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 38.64 Cr registered on 19 Dec 2022 with Charge ID 100657340 was modified on 05 Jul 2024. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 38.64 Cr with Charge ID 100806250 was registered on 18 Oct 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Respipure Pharma Private Limited?

The CIN of Respipure Pharma Private Limited is U24290MH2022PTC375528.

Where is Respipure Pharma Private Limited headquartered?

Respipure Pharma Private Limited is headquartered at Shop-75,Floor-7Th,Plot-215, Free Press, House Free Press Journal Marg, Nariman Point, Mumbai, Maharashtra, 400021.

When was Respipure Pharma Private Limited incorporated?

Respipure Pharma Private Limited was incorporated on 27 January 2022.

Who are the current directors of Respipure Pharma Private Limited?

The current directors of Respipure Pharma Private Limited are

What is the primary industry of Respipure Pharma Private Limited?

The primary industry of Respipure Pharma Private Limited is Manufacturing.

Is Respipure Pharma Private Limited a listed company?

Respipure Pharma Private Limited is unlisted.

What is the capital structure of Respipure Pharma Private Limited?

The authorized capital of Respipure Pharma Private Limited is ₹5.50 Cr, and the paid-up capital is ₹1.00 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available